|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
21.900 +0.140 (+0.643%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -7.250% | -11.573% | -19.062% | -20.198% | -7.539% |
| ROAE (%) | -14.103% | -19.655% | -27.370% | -27.328% | -10.412% |
| Return on Capital Employed (%) | -8.771% | -15.514% | -25.673% | -22.089% | -7.954% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 79.077% | 74.395% | 55.589% | 63.792% | 68.739% |
| EBITDA Margin (%) | -20.164% | -50.696% | -146.192% | -163.187% | -7.224% |
| Pre-tax Profit Margin (%) | -39.488% | -69.754% | -165.711% | -184.053% | -14.725% |
| Net Profit Margin (%) | -33.658% | -65.821% | -151.850% | -164.161% | -17.853% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.585 X | 1.690 X | 2.242 X | 4.061 X | 2.892 X |
| Quick Ratio (X) | 1.381 X | 1.460 X | 2.025 X | 3.723 X | 2.652 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 51.018% | 44.905% | 35.400% | 22.121% | 24.601% |
| Total Debt / Total Assets (%) | 33.429% | 27.138% | 15.741% | 10.509% | 5.685% |
| Net Debt / Total Assets (%) | 12.508% | 4.113% | -17.510% | -37.176% | -26.029% |
| Total Debt / Shareholders' Funds (%) | 68.542% | 49.857% | 24.942% | 13.909% | 7.891% |
| Long Term Debt / Shareholders' Funds (%) | 47.134% | 34.124% | 16.919% | 9.327% | 7.325% |
| Net Debt / Shareholders' Funds (%) | 25.646% | 7.556% | -27.745% | -49.207% | -36.132% |
| Net Cash / (Debt) ($) | (1.551B) | (444.209M) | 1.990B | 4.675B | 2.876B |
| Net Cash / (Debt) per share ($) | (1.512) | (0.451) | 2.018 | 4.757 | 3.158 |
| Total Debt / Capital Employed (%) | 43.234% | 35.457% | 20.125% | 12.235% | 6.954% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 404.125 Day | 410.657 Day | 310.983 Day | 375.770 Day | 120.105 Day |
| Receivables Turnover (Day) | 74.256 Day | 92.691 Day | 86.534 Day | 191.561 Day | 88.703 Day |
| Payables Turnover (Day) | 23.331 Day | 42.678 Day | 64.236 Day | 59.993 Day | 13.010 Day |
| Remarks: | Real time quote last updated: 20/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -840,910 |
| %Change | -34.427% |
| EPS / (LPS) | RMB -0.840 |
| NBV Per Share (¥) | RMB 5.895 |